RxDoctor Payments Data

Steven Atchison, MD

Orthopaedic Surgery · Shreveport, LANPI 1447242276

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $130,100 of the $169,820 with a category attached, or 76.6%. Stryker accounts for 85.8% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2019 at $45,831 and has fallen 70.9% since, to $13,327 in 2025. Among orthopaedic surgery clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$169,820in general payments, 2019–2025

Across 280 payments — averaging $606.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$146K
  • Heron Therapeutics, Inc.$14K
  • Medtronic$9K
  • Smith+Nephew$335
  • AbbVie$141
  • Pacira Pharmaceuticals Incorporated$125
  • plus $698 from 16 others

What the payments were for

  • Consulting fees$130,10077%
  • Speaking & faculty fees$13,7158%
  • Travel & lodging$16,90210%
  • Food & beverage$9,1045%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$169,820 in reported general payments places this provider in the 95th percentile of 286 orthopaedic surgery providers in Louisiana.

See all orthopaedic surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$625,021
Medicare patients
911
Services billed
5,394

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Daptomycin14$20,132
Tranexamic Acid13$337
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen17$185
Dexamethasone13$94
Sodium Chloride0.9 % Sodium Chloride13$55

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Shreveport

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →